Magdalena Görtz

Priv. Doz. Dr. Magdalena Görtz is a Group Leader at the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, leading a Junior Clinical Cooperation Unit focused on prostate cancer research. Her work emphasizes non-invasive early detection and risk stratification of aggressive prostate cancers, integrating clinical, molecular, and imaging data with machine learning.

Her research team combines expertise from medicine, molecular biology, and bioinformatics to develop predictive models and AI-driven tools, including a validated chatbot (PROSCA) for patient education. Collaborations with Siemens Healthineers and SAP SE bridge academic and industrial innovation.

Key projects include liquid biopsy analysis for tumor DNA markers, spatial tissue profiling, and digital twin modeling. Funding is supported by institutions like DKFZ and the University of Cambridge.